Autopsy report · NCT04177771

A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Technology changes.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years 1 month before it stopped.
34 participants enrolled.
Results were posted on the registry 3 years 1 month after it ended.

Vital statistics

Status: Terminated
Sponsor: RxSight, Inc.
Sponsor type: Industry
Conditions: Aphakia; Cataract; Presbyopia
Interventions: Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID Population; SofPort LI61AO IOL; Tecnis ZCB00 or ZTC150 IOL
Participants: 34
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.